Intelligent Bio Solutions (INBS) Income from Non-Controlling Interests (2019 - 2025)
Intelligent Bio Solutions' quarterly Income from Non-Controlling Interests came in at -$7148.0 in Q1 2025, up 21.43% year-on-year from -$5886.4 in Q1 2024, and up 2.44% quarter-over-quarter from -$7327.0 in Q4 2024.
Intelligent Bio Solutions has reported Income from Non-Controlling Interests for 7 years, with the latest figure at -$7148.0 in Q1 2025.
- For the quarter ending Q1 2025, Income from Non-Controlling Interests rose 21.43% year-over-year to -$7148.0; the trailing twelve-month figure through Mar 2025 stood at -$32739.0 (up 7.85% YoY), and the FY2023 full-year result was -$32835.0, down 17.58% from the prior year.
- Income from Non-Controlling Interests for Q1 2025 stood at -$7148.0, up from -$7327.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $2769.0 in Q2 2021, with the low at -$14854.0 in Q1 2021.
- Average Income from Non-Controlling Interests over 5 years is -$7471.6, with a median of -$7273.5 recorded in 2023.
- Peak annual rise in Income from Non-Controlling Interests reached 139.76% in 2021, while the deepest fall reached 1100.27% in 2021.
- Tracing INBS's Income from Non-Controlling Interests over 5 years: stood at -$3825.0 in 2021, then plunged by 69.18% to -$6471.0 in 2022, then slipped by 4.19% to -$6742.0 in 2023, then declined by 8.68% to -$7327.0 in 2024, then grew by 2.44% to -$7148.0 in 2025.
- The last three Income from Non-Controlling Interests figures came in at -$7148.0 (Q1 2025), -$7327.0 (Q4 2024), and -$9166.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 100,000.00 |
| 10 | Intelligent Bio Solutions | 13.61 Mn | 12.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -7,148.00 |
| Dec 31, 2024 | -7,327.00 |
| Sep 30, 2024 | -9,166.00 |
| Mar 31, 2024 | -9,098.00 |
| Dec 31, 2023 | -6,742.00 |
| Sep 30, 2023 | -7,220.00 |
| Jun 30, 2023 | -12,468.00 |
| Mar 31, 2023 | -8,111.00 |
| Dec 31, 2022 | -6,471.00 |
| Sep 30, 2022 | -5,785.00 |
| Jun 30, 2022 | -10,025.00 |
| Mar 31, 2022 | -8,887.00 |
| Dec 31, 2021 | -3,825.00 |
| Sep 30, 2021 | -5,188.00 |
| Jun 30, 2021 | 2,769.00 |
| Mar 31, 2021 | -14,854.00 |
| Dec 31, 2020 | -6,425.00 |
| Sep 30, 2020 | -4,405.00 |
| Jun 30, 2020 | -6,964.00 |
| Mar 31, 2020 | 1,485.00 |
| Dec 31, 2019 | -16,715.00 |